相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease Dilemmas in Diagnosis and the Conundrum of Treatment
Christopher S. King et al.
CHEST (2020)
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
Saja Almaaitah et al.
INTEGRATED BLOOD PRESSURE CONTROL (2020)
New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension
Valentina Mercurio et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies
Raymond L. Benza et al.
CHEST (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis
Sara Jaafar et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review
Kazuhiko Kido et al.
PHARMACOTHERAPY (2019)
MACITENTAN IN PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: REAL-WORLD EVIDENCE FROM THE COMBINED OPUS/ORPHEUS DATA SETS
Vallerie McLaughlin et al.
CHEST (2019)
Diagnosis of pulmonary hypertension
Adaani Frost et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Risk stratification and medical therapy of pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis
George Hung et al.
CURRENT RHEUMATOLOGY REPORTS (2019)
Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension
Roham Zamanian et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
David Kylhammar et al.
EUROPEAN HEART JOURNAL (2018)
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study
J. Gerry Coghlan et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
Valentina Mercurio et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension
Steven Hsu et al.
CIRCULATION (2018)
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Jean-Luc Vachiery et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model
Valentina Mercurio et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
Martin Kolb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort
Matthew R. Lammi et al.
PULMONARY CIRCULATION (2018)
Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England
C. Martinez et al.
PULMONARY CIRCULATION (2018)
Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial
Pavel Jansa et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival
Andreu Fernandez-Codina et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Marc Humbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
John Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension
Monica Mukherjee et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Marius M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Athenais Boucly et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sean Gaine et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction
Khalil I. Bourji et al.
PULMONARY CIRCULATION (2017)
OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)
Kelly Chin et al.
CHEST (2017)
Pulmonary hypertension in systemic sclerosis: different phenotypes
David Launay et al.
EUROPEAN RESPIRATORY REVIEW (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension
Steven Hsu et al.
CIRCULATION (2016)
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial
Aryeh Fischer et al.
RESPIRATORY MEDICINE (2016)
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
Paul M. Hassoun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Rennie L. Rhee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
PVOD Is Highly Prevalent in Scleroderma Patients Undergoing Lung Transplant
Shikha Gupta et al.
CHEST (2015)
Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
Lewis J. Rubin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes
Benjamin W. Kelemen et al.
PULMONARY CIRCULATION (2015)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Marc Humbert et al.
CIRCULATION (2014)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
Andrew R. Goudie et al.
LANCET RESPIRATORY MEDICINE (2014)
Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2013)
Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
Guillaume Lefevre et al.
ARTHRITIS AND RHEUMATISM (2013)
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Neal F. Chaisson et al.
CHEST (2013)
Right Ventricular Dysfunction in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Ryan J. Tedford et al.
CIRCULATION-HEART FAILURE (2013)
Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature
Xiaoqin Yang et al.
CLINICAL RHEUMATOLOGY (2013)
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension
Benjamin D. Fox et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography
Maurizio Zompatori et al.
RADIOLOGIA MEDICA (2013)
Computed Tomography Findings of Pulmonary Venoocclusive Disease in Scleroderma Patients Presenting With Precapillary Pulmonary Hypertension
S. Guenther et al.
ARTHRITIS AND RHEUMATISM (2012)
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
J. Hurdman et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study
JA Aviña-Zubieta et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
Argyris Tzouvelekis et al.
PULMONARY MEDICINE (2012)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2012)
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
Marco Matucci-Cerinic et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Diagnosis and Classification of Systemic Sclerosis
Eric Hachulla et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease
Sergio Caravita et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2011)
Predicting Survival in Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)
Raymond L. Benza et al.
CIRCULATION (2010)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2010)
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies
Jerome Avouac et al.
JOURNAL OF RHEUMATOLOGY (2010)
Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases Impact of Interstitial Lung Disease
Stephen C. Mathai et al.
ARTHRITIS AND RHEUMATISM (2009)
The Three-Year Incidence of Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in a Multicenter Nationwide Longitudinal Study in France
Eric Hachulla et al.
ARTHRITIS AND RHEUMATISM (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
Validation of a treadmill six-minute walk test protocol for the evaluation of patients with pulmonary arterial hypertension
Viviane Moreira de Camargo et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2009)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galie et al.
CIRCULATION (2008)
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
Carlotta Nannini et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
Micah R. Fisher et al.
ARTHRITIS AND RHEUMATISM (2006)
Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease
S. N. C. Liossis et al.
RHEUMATOLOGY (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The role of exercise testing in the management of pulmonary arterial hypertension
RJ Oudiz
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
The right ventricle in pulmonary hypertension
KM Chin et al.
CORONARY ARTERY DISEASE (2005)
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease
RJ Oudiz et al.
CHEST (2004)
N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers
Y Allanore et al.
ARTHRITIS AND RHEUMATISM (2003)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
